THE FIRST GROUP RECEIVED SECOND LINE CHEMOTHERAPY WHICH IS EXPECTED TO DOUBLE THE LIFE EXPECTANCY VERSUS NO TREATMENT AT ALL AND THEN THE SECOND GROUP RECEIVED ONLY TUMOR TREATING FIELD THERAPY WHAT WE SAW IN THAT TRIAL IS THAT THAT THE